Bile acids in glucose metabolism in health and disease

Journal of Experimental Medicine

Volumn 215, Issue 2, 2018, Pages 383-396

  Shapiro, Hagit ^a   Kolodziejczyk, Aleksandra A ^a   Halstuch, Daniel ^a   Elinav, Eran ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; GLUCOSE; AUTACOID; CELL RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; G PROTEIN COUPLED RECEPTOR;

BILE ACID METABOLISM; DIABETOGENESIS; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HEALTH; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DIABETES MELLITUS; LIPID METABOLISM; METABOLISM;

ANIMALS; BILE ACIDS AND SALTS; DIABETES MELLITUS; GASTROINTESTINAL MICROBIOME; GLUCOSE; HUMANS; INFLAMMATION MEDIATORS; LIPID METABOLISM; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 85041424453     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20171965     Document Type: Review

References (146)

1. Ahlberg, J., B. Angelin, I. Björkhem, and K. Einarsson. 1977. Individual bile acids in portal venous and systemic blood serum of fasting man. Gastroenterology. 73:1377-1382
2. Ahmad, N.N., A. Pfalzer, and L.M. Kaplan. 2013. Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int. J. Obes. 37:1553-1559. https ://doi. org /10. 1038 /ijo. 2013. 38
3. Anderson, K.E., E. Kok, and N.B. Javitt. 1972. Bile acid synthesis in man: metabolism of 7α-hydroxycholesterol-14C and 26-hydroxycholesterol-3 H. J. Clin. Invest. 51:112-117. https ://doi. org /10. 1172 /JCI106780
4. Angelin, B., I. Björkhem, K. Einarsson, and S. Ewerth. 1982. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J. Clin. Invest. 70:724-731. https ://doi. org /10. 1172 /JCI110668
5. Balasubramaniyan, N., M. Ananthanarayanan, and F.J. Suchy. 2012. Direct methylation of FXR by Set7/9, a lysine methyltransferase, regulates the expression of FXR target genes. Am. J. Physiol. Gastrointest. Liver Physiol. 302:G937-G947. https ://doi. org /10. 1152 /ajpgi. 00441. 2011
6. Balderas, C., F.J. Rupérez, E. Ibañez, J. Señorans, J. Guerrero-Fernández, I.G. Casado, R. Gracia-Bouthelier, A. García, and C. Barbas. 2013. Plasma and urine metabolic fingerprinting of type 1 diabetic children. Electrophoresis. 34:2882-2890
7. Bathena, S.P., R. Thakare, N. Gautam, S. Mukherjee, M. Olivera, J. Meza, and Y. Alnouti. 2015. Urinary bile acids as biomarkers for liver diseases I. Stability of the baseline profile in healthy subjects. Toxicol. Sci. 143:296-307. https ://doi. org /10. 1093 /toxsci /kfu227
8. Benoit, B., E. Meugnier, M. Castelli, S. Chanon, A. Vieille-Marchiset, C. Durand, N. Bendridi, S. Pesenti, P.A. Monternier, A.C. Durieux, et al. 2017. Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice. Nat. Med. 23:990-996
9. Bernstein, H., C. Bernstein, C.M. Payne, and K. Dvorak. 2009. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J. Gastroenterol. 15:3329-3340. https ://doi. org /10. 3748 /wjg. 15. 3329
10. Berrabah, W., P. Aumercier, C. Gheeraert, H. Dehondt, E. Bouchaert, J. Alexandre, M. Ploton, C. Mazuy, S. Caron, A. Tailleux, et al. 2014. Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR). Hepatology. 59:2022-2033. https ://doi. org /10. 1002 /hep. 26710
11. Bhutta, H.Y., N. Rajpal, W. White, J.M. Freudenberg, Y. Liu, J. Way, D. Rajpal, D.C. Cooper, A. Young, A. Tavakkoli, and L. Chen. 2015. Effect of Rouxen-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats. PLoS One. 10:e0122273. https ://doi. org /10. 1371 /journal. pone. 0122273
12. Blahová, T., L. Peterková, M. Lenícek, M. Vlachová, K. Zemánková, V. Adámková, L. Vítek, and J. Kovár. 2016. The effect of colesevelam treatment on bile acid and lipid metabolism and glycemic control in healthy men. Physiol. Res. 65:995-1003
13. Briere, D.A., X. Ruan, C.C. Cheng, A.M. Siesky, T.E. Fitch, C. Dominguez, S.G. Sanfeliciano, C. Montero, C.S. Suen, Y. Xu, et al. 2015. Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice. PLoS One. 10:e0136873. https ://doi. org /10. 1371 /journal. pone. 0136873
14. Broeders, E.P., E.B. Nascimento, B. Havekes, B. Brans, K.H. Roumans, A. Tailleux, G. Schaart, M. Kouach, J. Charton, B. Deprez, et al. 2015. The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity. Cell Metab. 22:418-426. https ://doi. org /10. 1016 /j. cmet. 2015. 07. 002
15. Cariou, B., K. van Harmelen, D. Duran-Sandoval, T.H. van Dijk, A. Grefhorst, M. Abdelkarim, S. Caron, G. Torpier, J.C. Fruchart, F.J. Gonzalez, et al. 2006. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J. Biol. Chem. 281:11039-11049. https ://doi. org /10. 1074 /jbc. M510258200
16. Chen, L., X. Yao, A. Young, J. McNulty, D. Anderson, Y. Liu, C. Nystrom, D. Croom, S. Ross, J. Collins, et al. 2012. Inhibition of apical sodiumdependent bile acid transporter as a novel treatment for diabetes. Am. J. Physiol. Endocrinol. Metab. 302:E68-E76. https ://doi. org /10. 1152 / ajpendo. 00323. 2011
17. Cheng, S., M. Zou, Q. Liu, J. Kuang, J. Shen, S. Pu, L. Chen, H. Li, T. Wu, R. Li, et al. 2017. Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation. Am. J. Pathol. 187:808-818. https :// doi. org /10. 1016 /j. ajpath. 2016. 12. 013
18. Courcoulas, A.P., B.H. Goodpaster, J.K. Eagleton, S.H. Belle, M.A. Kalarchian, W. Lang, F.G. Toledo, and J.M. Jakicic. 2014. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg. 149:707-715. https ://doi. org /10. 1001 /jamasurg. 2014. 467
19. de Aguiar Vallim, T.Q., E.J. Tarling, and P.A. Edwards. 2013. Pleiotropic roles of bile acids in metabolism. Cell Metab. 17:657-669. https ://doi. org /10. 1016 /j. cmet. 2013. 03. 013
20. De Giorgi, S., V. Campos, L. Egli, U. Toepel, G. Carrel, B. Cariou, D. Rainteau, P. Schneiter, L. Tappy, and V. Giusti. 2015. Long-term effects of Rouxen-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study. Clin. Nutr. 34:911-917. https ://doi. org /10. 1016 /j. clnu. 2014. 09. 018
21. Degirolamo, C., S. Rainaldi, F. Bovenga, S. Murzilli, and A. Moschetta. 2014. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Reports. 7:12-18. https ://doi. org /10. 1016 /j. celrep. 2014. 02. 032
22. Devlin, A.S., and M.A. Fischbach. 2015. A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat. Chem. Biol. 11:685-690. https ://doi. org /10. 1038 /nchembio. 1864
23. Ding, L., K.M. Sousa, L. Jin, B. Dong, B.W. Kim, R. Ramirez, Z. Xiao, Y. Gu, Q. Yang, J. Wang, et al. 2016. Vertical sleeve gastrectomy activates GPB AR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice. Hepatology. 64:760-773. https ://doi. org /10. 1002 /hep. 28689
24. Duez, H., J.N. van der Veen, C. Duhem, B. Pourcet, T. Touvier, C. Fontaine, B. Derudas, E. Baugé, R. Havinga, V.W. Bloks, et al. 2008. Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha. Gastroenterology. 135:689-698. https ://doi. org /10. 1053 /j. gastro. 2008. 05. 035
25. Duran-Sandoval, D., B. Cariou, F. Percevault, N. Hennuyer, A. Grefhorst, T.H. van Dijk, F.J. Gonzalez, J.C. Fruchart, F. Kuipers, and B. Staels. 2005. The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J. Biol. Chem. 280:29971-29979. https ://doi. org /10. 1074 /jbc. M501931200
26. Dutia, R., M. Embrey, C.S. O'Brien, R.A. Haeusler, K.K. Agénor, P. Homel, J. McGinty, R.P. Vincent, J. Alaghband-Zadeh, B. Staels, et al. 2015. Temporal changes in bile acid levels and 12a-hydroxylation after Rouxen-Y gastric bypass surgery in type 2 diabetes. Int. J. Obes. 39:806-813. https ://doi. org /10. 1038 /ijo. 2015. 1
27. Dutta, T., Y.C. Kudva, X.M. Persson, L.A. Schenck, G.C. Ford, R.J. Singh, R. Carter, and K.S. Nair. 2016. Impact of Long-Term Poor and Good Glycemic Control on Metabolomics Alterations in Type 1 Diabetic People. J. Clin. Endocrinol. Metab. 101:1023-1033. https ://doi. org /10. 1210 /jc. 2015-2640
28. Eyssen, H., G. De Pauw, J. Stragier, and A. Verhulst. 1983. Cooperative formation of omega-muricholic acid by intestinal microorganisms. Appl. Environ. Microbiol. 45:141-147
29. Fang, S., J.M. Suh, S.M. Reilly, E. Yu, O. Osborn, D. Lackey, E. Yoshihara, A. Perino, S. Jacinto, Y. Lukasheva, et al. 2015. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat. Med. 21:159-165. https ://doi. org /10. 1038 /nm. 3760
30. Ferrannini, E., S. Camastra, B. Astiarraga, M. Nannipieri, J. Castro-Perez, D. Xie, L. Wang, M. Chakravarthy, and R.A. Haeusler. 2015. Increased Bile Acid Synthesis and Deconjugation After Biliopancreatic Diversion. Diabetes. 64:3377-3385. https ://doi. org /10. 2337 /db15-0214
31. Fonseca, V.A., Y. Handelsman, and B. Staels. 2010. Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence. Diabetes Obes. Metab. 12:384-392. https ://doi. org /10. 1111 /j. 1463-1326. 2009. 01181. x
32. Forman, B.M., E. Goode, J. Chen, A.E. Oro, D.J. Bradley, T. Perlmann, D.J. Noonan, L.T. Burka, T. McMorris, W.W. Lamph, et al. 1995. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 81:687-693. https ://doi. org /10. 1016 /0092-8674(95)90530-8
33. Fu, L., L.M. John, S.H. Adams, X.X. Yu, E. Tomlinson, M. Renz, P.M. Williams, R. Soriano, R. Corpuz, B. Moffat, et al. 2004. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology. 145:2594-2603. https ://doi. org /10. 1210 /en. 2003-1671
34. Gälman, C., B. Angelin, and M. Rudling. 2005. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology. 129:1445-1453. https ://doi. org /10. 1053 /j. gastro. 2005. 09. 009
35. Gälman, C., B. Angelin, and M. Rudling. 2011. Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. J. Intern. Med. 270:580-588. https ://doi. org /10. 1111 /j. 1365-2796. 2011. 02466. x
36. Gilliland, S.E., and M.L. Speck. 1977. Deconjugation of bile acids by intestinal lactobacilli. Appl. Environ. Microbiol. 33:15-18
37. Gineste, R., A. Sirvent, R. Paumelle, S. Helleboid, A. Aquilina, R. Darteil, D.W. Hum, J.C. Fruchart, and B. Staels. 2008. Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity. Mol. Endocrinol. 22:2433-2447. https ://doi. org /10. 1210 /me. 2008-0092
38. Glicksman, C., D.J. Pournaras, M. Wright, R. Roberts, D. Mahon, R. Welbourn, R. Sherwood, J. Alaghband-Zadeh, and C.W. le Roux. 2010. Postprandial plasma bile acid responses in normal weight and obese subjects. Ann. Clin. Biochem. 47:482-484. https ://doi. org /10. 1258 /acb. 2010. 010040
39. Goncalves, D., A. Barataud, F. De Vadder, J. Vinera, C. Zitoun, A. Duchampt, and G. Mithieux. 2015. Bile Routing Modification Reproduces Key Features of Gastric Bypass in Rat. Ann. Surg. 262:1006-1015. https :// doi. org /10. 1097 /SLA. 0000000000001121
40. Goodwin, B., S.A. Jones, R.R. Price, M.A. Watson, D.D. McKee, L.B. Moore, C. Galardi, J.G. Wilson, M.C. Lewis, M.E. Roth, et al. 2000. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell. 6:517-526. https ://doi. org /10. 1016 /S1097-2765(00)00051-4
41. Guo, C., H. Qi, Y. Yu, Q. Zhang, J. Su, D. Yu, W. Huang, W.D. Chen, and Y.D. Wang. 2015. The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway. Front. Pharmacol. 6:287. https ://doi. org /10. 3389 / fphar. 2015. 00287
42. Guo, C., S. Xie, Z. Chi, J. Zhang, Y. Liu, L. Zhang, M. Zheng, X. Zhang, D. Xia, Y. Ke, et al. 2016. Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome. Immunity. 45:802-816. https ://doi. org /10. 1016 /j. immuni. 2016. 09. 008
43. Haeusler, R.A., M. Pratt-Hyatt, C.L. Welch, C.D. Klaassen, and D. Accili. 2012. Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. Cell Metab. 15:65-74. https ://doi. org /10. 1016 /j. cmet. 2011. 11. 010
44. Haeusler, R.A., B. Astiarraga, S. Camastra, D. Accili, and E. Ferrannini. 2013. Human insulin resistance is associated with increased plasma levels of 12a-hydroxylated bile acids. Diabetes. 62:4184-4191. https ://doi. org /10. 2337 /db13-0639
45. Haeusler, R.A., S. Camastra, M. Nannipieri, B. Astiarraga, J. Castro-Perez, D. Xie, L. Wang, M. Chakravarthy, and E. Ferrannini. 2016. Increased Bile Acid Synthesis and Impaired Bile Acid Transport in Human Obesity. J. Clin. Endocrinol. Metab. 101:1935-1944. https ://doi. org /10. 1210 /jc. 2015-2583
46. Han, S., R. Zhang, R. Jain, H. Shi, L. Zhang, G. Zhou, P. Sangwung, D. Tugal, G.B. Atkins, D.A. Prosdocimo, et al. 2015. Circadian control of bile acid synthesis by a KLF15-Fgf15 axis. Nat. Commun. 6:7231. https ://doi. org /10. 1038 /ncomms8231
47. Hansen, M., D.P. Sonne, K.H. Mikkelsen, L.L. Gluud, T. Vilsbøll, and F.K. Knop. 2017. Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials. J. Diabetes Complications. 31:918-927. https ://doi. org /10. 1016 /j. jdiacomp. 2017. 01. 011
48. Hashiguchi, T., S. Arakawa, S. Takahashi, F.J. Gonzalez, T. Sueyoshi, and M. Negishi. 2016. Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation. Mol. Endocrinol. 30:1070-1080. https ://doi. org /10. 1210 /me. 2016-1105
49. Henao-Mejia, J., E. Elinav, C. Jin, L. Hao, W.Z. Mehal, T. Strowig, C.A. Thaiss, A.L. Kau, S.C. Eisenbarth, M.J. Jurczak, et al. 2012. Inflammasomemediated dysbiosis regulates progression of NAF LD and obesity. Nature. 482:179-185
50. Ho, J.E., M.G. Larson, R.S. Vasan, A. Ghorbani, S. Cheng, E.P. Rhee, J.C. Florez, C.B. Clish, R.E. Gerszten, and T.J. Wang. 2013. Metabolite profiles during oral glucose challenge. Diabetes. 62:2689-2698. https :// doi. org /10. 2337 /db12-0754
51. Hodge, R.J., and D.J. Nunez. 2016. Therapeutic potential of Takeda-Gprotein-receptor-5 (TGR5) agonists. Hope or hype? Diabetes Obes. Metab. 18:439-443. https ://doi. org /10. 1111 /dom. 12636
52. Högenauer, K., L. Arista, N. Schmiedeberg, G. Werner, H. Jaksche, R. Bouhelal, D.G. Nguyen, B.G. Bhat, L. Raad, C. Rauld, and J.M. Carballido. 2014. G-protein-coupled bile acid receptor 1 (GPB AR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype. J. Med. Chem. 57:10343-10354. https ://doi. org /10. 1021 /jm501052c
53. Inagaki, T., M. Choi, A. Moschetta, L. Peng, C.L. Cummins, J.G. McDonald, G. Luo, S.A. Jones, B. Goodwin, J.A. Richardson, et al. 2005. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2:217-225. https ://doi. org /10. 1016 /j. cmet. 2005. 09. 001
54. Ishibashi, S., M. Schwarz, P.K. Frykman, J. Herz, and D.W. Russell. 1996. Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. J. Biol. Chem. 271:18017-18023. https ://doi. org /10. 1074 /jbc. 271. 30. 18017
55. Islam, K.B., S. Fukiya, M. Hagio, N. Fujii, S. Ishizuka, T. Ooka, Y. Ogura, T. Hayashi, and A. Yokota. 2011. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology. 141:1773-1781. https ://doi. org /10. 1053 /j. gastro. 2011. 07. 046
56. Jiang, C., C. Xie, F. Li, L. Zhang, R.G. Nichols, K.W. Krausz, J. Cai, Y. Qi, Z.Z. Fang, S. Takahashi, et al. 2015a. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J. Clin. Invest. 125:386-402. https ://doi. org /10. 1172 /JCI76738
57. Jiang, C., C. Xie, Y. Lv, J. Li, K.W. Krausz, J. Shi, C.N. Brocker, D. Desai, S.G. Amin, W.H. Bisson, et al. 2015b. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat. Commun. 6:10166. https ://doi. org /10. 1038 /ncomms10166
58. Jones, B.V., M. Begley, C. Hill, C.G. Gahan, and J.R. Marchesi. 2008. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc. Natl. Acad. Sci. USA. 105:13580-13585. https ://doi. org /10. 1073 /pnas. 0804437105
59. Jørgensen, N.B., C. Dirksen, K.N. Bojsen-Møller, V.B. Kristiansen, B.S. Wulff, D. Rainteau, L. Humbert, J.F. Rehfeld, J.J. Holst, S. Madsbad, and T.R. Clausen. 2015. Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations. J. Clin. Endocrinol. Metab. 100:E396-E406. https ://doi. org /10. 1210 /jc. 2014-1658
60. Kakiyama, G., W.M. Pandak, P.M. Gillevet, P.B. Hylemon, D.M. Heuman, K. Daita, H. Takei, A. Muto, H. Nittono, J.M. Ridlon, et al. 2013. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J. Hepatol. 58:949-955. https ://doi. org /10. 1016 /j. jhep. 2013. 01. 003
61. Katsuma, S., A. Hirasawa, and G. Tsujimoto. 2005. Bile acids promote glucagonlike peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem. Biophys. Res. Commun. 329:386-390. https :// doi. org /10. 1016 /j. bbrc. 2005. 01. 139
62. Kawamata, Y., R. Fujii, M. Hosoya, M. Harada, H. Yoshida, M. Miwa, S. Fukusumi, Y. Habata, T. Itoh, Y. Shintani, et al. 2003. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278:9435-9440. https :// doi. org /10. 1074 /jbc. M209706200
63. Kellogg, T.F., and B.S. Wostmann. 1969. Fecal neutral steroids and bile acids from germfree rats. J. Lipid Res. 10:495-503
64. Kemper, J.K., Z. Xiao, B. Ponugoti, J. Miao, S. Fang, D. Kanamaluru, S. Tsang, S.Y. Wu, C.M. Chiang, and T.D. Veenstra. 2009. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 10:392-404. https ://doi. org /10. 1016 /j. cmet. 2009. 09. 009
65. Kim, D.H., Z. Xiao, S. Kwon, X. Sun, D. Ryerson, D. Tkac, P. Ma, S.Y. Wu, C.M. Chiang, E. Zhou, et al. 2015. A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity. EMBO J. 34:184-199. https ://doi. org /10. 15252 /embj. 201489527
66. Kim, I., K. Morimura, Y. Shah, Q. Yang, J.M. Ward, and F.J. Gonzalez. 2007. Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis. 28:940-946. https ://doi. org /10. 1093 /carcin /bgl249
67. Kim, K.H., S. Choi, Y. Zhou, E.Y. Kim, J.M. Lee, P.K. Saha, S. Anakk, and D.D. Moore. 2017. Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice. Hepatology. 66:498-509. https ://doi. org /10. 1002 /hep. 29199
68. Kir, S., S.A. Beddow, V.T. Samuel, P. Miller, S.F. Previs, K. Suino-Powell, H.E. Xu, G.I. Shulman, S.A. Kliewer, and D.J. Mangelsdorf. 2011. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science. 331:1621-1624. https ://doi. org /10. 1126 / science. 1198363
69. Kirwan, W.O., A.N. Smith, W.D. Mitchell, J.D. Falconer, and M.A. Eastwood. 1975. Bile acids and colonic motility in the rabbit and the human. Gut. 16:894-902. https ://doi. org /10. 1136 /gut. 16. 11. 894
70. Kobayashi, M., H. Ikegami, T. Fujisawa, K. Nojima, Y. Kawabata, S. Noso, N. Babaya, M. Itoi-Babaya, K. Yamaji, Y. Hiromine, et al. 2007. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acidbinding resin. Diabetes. 56:239-247. https ://doi. org /10. 2337 /db06-0353
71. Kohli, R., K.D. Setchell, M. Kirby, A. Myronovych, K.K. Ryan, S.H. Ibrahim, J. Berger, K. Smith, M. Toure, S.C. Woods, and R.J. Seeley. 2013. A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. Endocrinology. 154:2341-2351. https ://doi. org /10. 1210 /en. 2012-2069
72. Kong, B., Y. Zhu, G. Li, J.A. Williams, K. Buckley, O. Tawfik, J.P. Luyendyk, and G.L. Guo. 2016. Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 310:G295-G302. https ://doi. org /10. 1152 /ajpgi. 00134. 2015
73. Kuipers, F., J.H. Stroeve, S. Caron, and B. Staels. 2007. Bile acids, farnesoid X receptor, atherosclerosis and metabolic control. Curr. Opin. Lipidol. 18:289-297. https ://doi. org /10. 1097 /MOL. 0b013e3281338d08
74. Kumar, D.P., S. Rajagopal, S. Mahavadi, F. Mirshahi, J.R. Grider, K.S. Murthy, and A.J. Sanyal. 2012. Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells. Biochem. Biophys. Res. Commun. 427:600-605. https ://doi. org /10. 1016 /j. bbrc. 2012. 09. 104
75. Kumar, D.P., A. Asgharpour, F. Mirshahi, S.H. Park, S. Liu, Y. Imai, J.L. Nadler, J.R. Grider, K.S. Murthy, and A.J. Sanyal. 2016. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet a Cells to Promote Glucose Homeostasis. J. Biol. Chem. 291:6626-6640. https ://doi. org /10. 1074 /jbc. M115. 699504
76. Lasalle, M., V. Hoguet, N. Hennuyer, F. Leroux, C. Piveteau, L. Belloy, S. Lestavel, E. Vallez, E. Dorchies, I. Duplan, et al. 2017. Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance. J. Med. Chem. 60:4185-4211. https ://doi. org /10. 1021 /acs. jmedchem. 6b01873
77. Lee, J.M., M. Wagner, R. Xiao, K.H. Kim, D. Feng, M.A. Lazar, and D.D. Moore. 2014. Nutrient-sensing nuclear receptors coordinate autophagy. Nature. 516:112-115
78. Lefebvre, P., B. Cariou, F. Lien, F. Kuipers, and B. Staels. 2009. Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 89:147-191. https ://doi. org /10. 1152 /physrev. 00010. 2008
79. Le Martelot, G., T. Claudel, D. Gatfield, O. Schaad, B. Kornmann, G. Lo Sasso, A. Moschetta, and U. Schibler. 2009. REV-ERBalpha participates in circadian SRE BP signaling and bile acid homeostasis. PLoS Biol. 7:e1000181. https ://doi. org /10. 1371 /journal. pbio. 1000181
80. Li, T., and J.Y. Chiang. 2014. Bile acid signaling in metabolic disease and drug therapy. Pharmacol. Rev. 66:948-983. https ://doi. org /10. 1124 /pr. 113. 008201
81. Li, F., C. Jiang, K.W. Krausz, Y. Li, I. Albert, H. Hao, K.M. Fabre, J.B. Mitchell, A.D. Patterson, and F.J. Gonzalez. 2013. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat. Commun. 4:2384. https ://doi. org /10. 1038 /ncomms3384
82. Li, T., E. Owsley, M. Matozel, P. Hsu, C.M. Novak, and J.Y. Chiang. 2010. Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice. Hepatology. 52:678-690. https ://doi. org /10. 1002 /hep. 23721
83. Li, T., J.M. Francl, S. Boehme, A. Ochoa, Y. Zhang, C.D. Klaassen, S.K. Erickson, and J.Y. Chiang. 2012. Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity. J. Biol. Chem. 287:1861-1873. https ://doi. org /10. 1074 /jbc. M111. 305789
84. Lien, F., A. Berthier, E. Bouchaert, C. Gheeraert, J. Alexandre, G. Porez, J. Prawitt, H. Dehondt, M. Ploton, S. Colin, et al. 2014. Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk. J. Clin. Invest. 124:1037-1051. https ://doi. org /10. 1172 /JCI68815
85. Liu, H., P. Pathak, S. Boehme, and J.Y. Chiang. 2016. Cholesterol 7a-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis. J. Lipid Res. 57:1831-1844. https :// doi. org /10. 1194 /jlr. M069807
86. Lutz, T.A., and M. Bueter. 2014. The physiology underlying Roux-en-Y gastric bypass: a status report. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307:R1275-R1291. https ://doi. org /10. 1152 /ajpregu. 00185. 2014
87. Ma, K., P.K. Saha, L. Chan, and D.D. Moore. 2006. Farnesoid X receptor is essential for normal glucose homeostasis. J. Clin. Invest. 116:1102-1109. https ://doi. org /10. 1172 /JCI25604
88. Makishima, M., A.Y. Okamoto, J.J. Repa, H. Tu, R.M. Learned, A. Luk, M.V. Hull, K.D. Lustig, D.J. Mangelsdorf, and B. Shan. 1999. Identification of a nuclear receptor for bile acids. Science. 284:1362-1365. https ://doi. org /10. 1126 /science. 284. 5418. 1362
89. Makishima, M., T.T. Lu, W. Xie, G.K. Whitfield, H. Domoto, R.M. Evans, M.R. Haussler, and D.J. Mangelsdorf. 2002. Vitamin D receptor as an intestinal bile acid sensor. Science. 296:1313-1316. https ://doi. org /10. 1126 /science. 1070477
90. McGavigan, A.K., D. Garibay, Z.M. Henseler, J. Chen, A. Bettaieb, F.G. Haj, R.E. Ley, M.L. Chouinard, and B.P. Cummings. 2017. TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice. Gut. 66:226-234. https ://doi. org /10. 1136 /gutjnl-2015-309871
91. Morton, G.J., M.E. Matsen, D.P. Bracy, T.H. Meek, H.T. Nguyen, D. Stefanovski, R.N. Bergman, D.H. Wasserman, and M.W. Schwartz. 2013. FGF19 action in the brain induces insulin-independent glucose lowering. J. Clin. Invest. 123:4799-4808. https ://doi. org /10. 1172 / JCI70710
92. Mudaliar, S., R.R. Henry, A.J. Sanyal, L. Morrow, H.U. Marschall, M. Kipnes, L. Adorini, C.I. Sciacca, P. Clopton, E. Castelloe, et al. 2013. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology. 145:574-582. https ://doi. org /10. 1053 /j. gastro. 2013. 05. 042
93. Nagahashi, M., K. Yuza, Y. Hirose, M. Nakajima, R. Ramanathan, N.C. Hait, P.B. Hylemon, H. Zhou, K. Takabe, and T. Wakai. 2016. The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases. J. Lipid Res. 57:1636-1643. https ://doi. org /10. 1194 /jlr. R069286
94. Neuschwander-Tetri, B.A., R. Loomba, A.J. Sanyal, J.E. Lavine, M.L. Van Natta, M.F. Abdelmalek, N. Chalasani, S. Dasarathy, A.M. Diehl, B. Hameed, et al. NASH Clinical Research Network. 2015. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, nonalcoholic steatohepatitis (FLI NT): a multicentre, randomised, placebocontrolled trial. Lancet. 385:956-965. https ://doi. org /10. 1016 /S0140-6736(14)61933-4
95. Parks, D.J., S.G. Blanchard, R.K. Bledsoe, G. Chandra, T.G. Consler, S.A. Kliewer, J.B. Stimmel, T.M. Willson, A.M. Zavacki, D.D. Moore, and J.M. Lehmann. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science. 284:1365-1368. https ://doi. org /10. 1126 /science. 284. 5418. 1365
96. Parséus, A., N. Sommer, F. Sommer, R. Caesar, A. Molinaro, M. Ståhlman, T.U. Greiner, R. Perkins, and F. Bäckhed. 2017. Microbiota-induced obesity requires farnesoid X receptor. Gut. 66:429-437. https ://doi. org /10. 1136 /gutjnl-2015-310283
97. Patti, M.E., S.M. Houten, A.C. Bianco, R. Bernier, P.R. Larsen, J.J. Holst, M.K. Badman, E. Maratos-Flier, E.C. Mun, J. Pihlajamaki, et al. 2009. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring). 17:1671-1677. https ://doi. org /10. 1038 /oby. 2009. 102
98. Pellicciari, R., A. Gioiello, A. Macchiarulo, C. Thomas, E. Rosatelli, B. Natalini, R. Sardella, M. Pruzanski, A. Roda, E. Pastorini, et al. 2009. Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity. J. Med. Chem. 52:7958-7961. https ://doi. org /10. 1021 /jm901390p
99. Perino, A., T.W. Pols, M. Nomura, S. Stein, R. Pellicciari, and K. Schoonjans. 2014. TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation. J. Clin. Invest. 124:5424-5436. https :// doi. org /10. 1172 /JCI76289
100. Picard, A., J. Soyer, X. Berney, D. Tarussio, S. Quenneville, M. Jan, E. Grouzmann, F. Burdet, M. Ibberson, and B. Thorens. 2016. A Genetic Screen Identifies Hypothalamic Fgf15 as a Regulator of Glucagon Secretion. Cell Reports. 17:1795-1806. https ://doi. org /10. 1016 /j. celrep. 2016. 10. 041
101. Pols, T.W., M. Nomura, T. Harach, G. Lo Sasso, M.H. Oosterveer, C. Thomas, G. Rizzo, A. Gioiello, L. Adorini, R. Pellicciari, et al. 2011. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab. 14:747-757. https ://doi. org /10. 1016 /j. cmet. 2011. 11. 006
102. Potthoff, M.J., J. Boney-Montoya, M. Choi, T. He, N.E. Sunny, S. Satapati, K. Suino-Powell, H.E. Xu, R.D. Gerard, B.N. Finck, et al. 2011. FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1a pathway. Cell Metab. 13:729-738. https ://doi. org /10. 1016 /j. cmet. 2011. 03. 019
103. Potthoff, M.J., A. Potts, T. He, J.A. Duarte, R. Taussig, D.J. Mangelsdorf, S.A. Kliewer, and S.C. Burgess. 2013. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. Am. J. Physiol. Gastrointest. Liver Physiol. 304:G371-G380. https :// doi. org /10. 1152 /ajpgi. 00400. 2012
104. Prawitt, J., M. Abdelkarim, J.H. Stroeve, I. Popescu, H. Duez, V.R. Velagapudi, J. Dumont, E. Bouchaert, T.H. van Dijk, A. Lucas, et al. 2011. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes. 60:1861-1871. https ://doi. org /10. 2337 /db11-0030
105. Rao, A., A. Kosters, J.E. Mells, W. Zhang, K.D. Setchell, A.M. Amanso, G.M. Wynn, T. Xu, B.T. Keller, H. Yin, et al. 2016. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice. Sci. Transl. Med. 8:357ra122. https ://doi. org /10. 1126 / scitranslmed. aaf4823
106. Rathinam, V.A., and K.A. Fitzgerald. 2016. Inflammasome Complexes: Emerging Mechanisms and Effector Functions. Cell. 165:792-800. https ://doi. org /10. 1016 /j. cell. 2016. 03. 046
107. Renga, B., A. Mencarelli, P. Vavassori, V. Brancaleone, and S. Fiorucci. 2010. The bile acid sensor FXR regulates insulin transcription and secretion. Biochim. Biophys. Acta. 1802:363-372. https ://doi. org /10. 1016 /j. bbadis. 2010. 01. 002
108. Ryan, K.K., R. Kohli, R. Gutierrez-Aguilar, S.G. Gaitonde, S.C. Woods, and R.J. Seeley. 2013. Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. Endocrinology. 154:9-15. https ://doi. org /10. 1210 /en. 2012-1891
109. Ryan, K.K., V. Tremaroli, C. Clemmensen, P. Kovatcheva-Datchary, A. Myronovych, R. Karns, H.E. Wilson-Pérez, D.A. Sandoval, R. Kohli, F. Bäckhed, and R.J. Seeley. 2014. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 509:183-188. https ://doi. org /10. 1038 /nature13135
110. Sachdev, S., Q. Wang, C. Billington, J. Connett, L. Ahmed, W. Inabnet, S. Chua, S. Ikramuddin, and J. Korner. 2016. FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes. Obes. Surg. 26:957-965. https ://doi. org /10. 1007 /s11695-015-1834-0
111. Sawey, E.T., M. Chanrion, C. Cai, G. Wu, J. Zhang, L. Zender, A. Zhao, R.W. Busuttil, H. Yee, L. Stein, et al. 2011. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell. 19:347-358. https ://doi. org /10. 1016 /j. ccr. 2011. 01. 040
112. Sayin, S.I., A. Wahlström, J. Felin, S. Jäntti, H.U. Marschall, K. Bamberg, B. Angelin, T. Hyötyläinen, M. Orešic, and F. Bäckhed. 2013. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17:225-235. https ://doi. org /10. 1016 /j. cmet. 2013. 01. 003
113. Schauer, P.R., D.L. Bhatt, J.P. Kirwan, K. Wolski, A. Aminian, S.A. Brethauer, S.D. Navaneethan, R.P. Singh, C.E. Pothier, S.E. Nissen, and S.R. Kashyap. STA MPE DE Investigators. 2017. Bariatric Surgery versus Intensive Medical Therapy for Diabetes-5-Year Outcomes. N. Engl. J. Med. 376:641-651. https ://doi. org /10. 1056 /NEJMoa1600869
114. Schittenhelm, B., R. Wagner, V. Kähny, A. Peter, P. Krippeit-Drews, M. Düfer, and G. Drews. 2015. Role of FXR in β-cells of lean and obese mice. Endocrinology. 156:1263-1271. https ://doi. org /10. 1210 /en. 2014-1751
115. Schwarz, M., E.G. Lund, K.D. Setchell, H.J. Kayden, J.E. Zerwekh, I. Björkhem, J. Herz, and D.W. Russell. 1996. Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase. J. Biol. Chem. 271:18024-18031. https ://doi. org /10. 1074 /jbc. 271. 30. 18024
116. Seok, S., T. Fu, S.E. Choi, Y. Li, R. Zhu, S. Kumar, X. Sun, G. Yoon, Y. Kang, W. Zhong, et al. 2014. Transcriptional regulation of autophagy by an FXRCREB axis. Nature. 516:108-111
117. Seol, W., H.S. Choi, and D.D. Moore. 1995. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol. 9:72-85
118. Shaham, O., R. Wei, T.J. Wang, C. Ricciardi, G.D. Lewis, R.S. Vasan, S.A. Carr, R. Thadhani, R.E. Gerszten, and V.K. Mootha. 2008. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol. Syst. Biol. 4:214. https ://doi. org /10. 1038 /msb. 2008. 50
119. Sheikh Abdul Kadir, S.H., M. Miragoli, S. Abu-Hayyeh, A.V. Moshkov, Q. Xie, V. Keitel, V.O. Nikolaev, C. Williamson, and J. Gorelik. 2010. Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes. PLoS One. 5:e9689. https ://doi. org /10. 1371 /journal. pone. 0009689
120. Staudinger, J.L., B. Goodwin, S.A. Jones, D. Hawkins-Brown, K.I. MacKenzie, A. LaTour, Y. Liu, C.D. Klaassen, K.K. Brown, J. Reinhard, et al. 2001. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. USA. 98:3369-3374. https ://doi. org /10. 1073 /pnas. 051551698
121. Steinert, R.E., R. Peterli, S. Keller, A.C. Meyer-Gerspach, J. Drewe, T. Peters, and C. Beglinger. 2013. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity (Silver Spring). 21:E660-E668. https ://doi. org /10. 1002 /oby. 20522
122. Su, J., Q. Zhang, H. Qi, L. Wu, Y. Li, D. Yu, W. Huang, W.D. Chen, and Y.D. Wang. 2017. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) protects against renal inflammation and renal cancer cell proliferation and migration through antagonizing NF-κB and STAT3 signaling pathways. Oncotarget. 8:54378-54387
123. Swann, J.R., E.J. Want, F.M. Geier, K. Spagou, I.D. Wilson, J.E. Sidaway, J.K. Nicholson, and E. Holmes. 2011. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc. Natl. Acad. Sci. USA. 108(Suppl 1):4523-4530. https ://doi. org /10. 1073 /pnas. 1006734107
124. Thomas, C., A. Gioiello, L. Noriega, A. Strehle, J. Oury, G. Rizzo, A. Macchiarulo, H. Yamamoto, C. Mataki, M. Pruzanski, et al. 2009. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 10:167-177. https ://doi. org /10. 1016 /j. cmet. 2009. 08. 001
125. Trabelsi, M.S., M. Daoudi, J. Prawitt, S. Ducastel, V. Touche, S.I. Sayin, A. Perino, C.A. Brighton, Y. Sebti, J. Kluza, et al. 2015. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat. Commun. 6:7629. https ://doi. org /10. 1038 /ncomms8629
126. Vandanmagsar, B., Y.H. Youm, A. Ravussin, J.E. Galgani, K. Stadler, R.L. Mynatt, E. Ravussin, J.M. Stephens, and V.D. Dixit. 2011. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17:179-188. https ://doi. org /10. 1038 /nm. 2279
127. van Dijk, T.H., A. Grefhorst, M.H. Oosterveer, V.W. Bloks, B. Staels, D.J. Reijngoud, and F. Kuipers. 2009. An increased flux through the glucose 6-phosphate pool in enterocytes delays glucose absorption in Fxr-/-mice. J. Biol. Chem. 284:10315-10323. https ://doi. org /10. 1074 /jbc. M807317200
128. Vlahcevic, Z.R., J.R. Miller, J.T. Farrar, and L. Swell. 1971. Kinetics and pool size of primary bile acids in man. Gastroenterology. 61:85-90
129. Wahlström, A., S.I. Sayin, H.U. Marschall, and F. Bäckhed. 2016. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. Cell Metab. 24:41-50. https ://doi. org /10. 1016 /j. cmet. 2016. 05. 005
130. Wahlström, A., P. Kovatcheva-Datchary, M. Ståhlman, M.T. Khan, F. Bäckhed, and H.U. Marschall. 2017. Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota. J. Lipid Res. 58:412-419. https ://doi. org /10. 1194 /jlr. M072819
131. Wang, H., J. Chen, K. Hollister, L.C. Sowers, and B.M. Forman. 1999. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell. 3:543-553. https ://doi. org /10. 1016 /S1097-2765(00)80348-2
132. Wang, Y.D., W.D. Chen, D. Yu, B.M. Forman, and W. Huang. 2011. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice. Hepatology. 54:1421-1432. https ://doi. org /10. 1002 /hep. 24525
133. Watanabe, M., S.M. Houten, L. Wang, A. Moschetta, D.J. Mangelsdorf, R.A. Heyman, D.D. Moore, and J. Auwerx. 2004. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SRE BP-1c. J. Clin. Invest. 113:1408-1418. https ://doi. org /10. 1172 /JCI21025
134. Watanabe, M., S.M. Houten, C. Mataki, M.A. Christoffolete, B.W. Kim, H. Sato, N. Messaddeq, J.W. Harney, O. Ezaki, T. Kodama, et al. 2006. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 439:484-489. https ://doi. org /10. 1038 / nature04330
135. Watanabe, M., Y. Horai, S.M. Houten, K. Morimoto, T. Sugizaki, E. Arita, C. Mataki, H. Sato, Y. Tanigawara, K. Schoonjans, et al. 2011. Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J. Biol. Chem. 286:26913-26920. https ://doi. org /10. 1074 /jbc. M111. 248203
136. Wickremesekera, K., G. Miller, T.D. Naotunne, G. Knowles, and R.S. Stubbs. 2005. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes. Surg. 15:474-481. https ://doi. org /10. 1381 /0960892053723402
137. Worthmann, A., C. John, M.C. Rühlemann, M. Baguhl, F.A. Heinsen, N. Schaltenberg, M. Heine, C. Schlein, I. Evangelakos, C. Mineo, et al. 2017. Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis. Nat. Med. 23:839-849. https ://doi. org /10. 1038 /nm. 4357
138. Wu, Y., C.J. Aquino, D.J. Cowan, D.L. Anderson, J.L. Ambroso, M.J. Bishop, E.E. Boros, L. Chen, A. Cunningham, R.L. Dobbins, et al. 2013. Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes. J. Med. Chem. 56:5094-5114. https ://doi. org /10. 1021 /jm400459m
139. Xie, C., C. Jiang, J. Shi, X. Gao, D. Sun, L. Sun, T. Wang, S. Takahashi, M. Anitha, K.W. Krausz, et al. 2017. An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice. Diabetes. 66:613-626. https ://doi. org /10. 2337 /db16-0663
140. Yang, F., X. Huang, T. Yi, Y. Yen, D.D. Moore, and W. Huang. 2007. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res. 67:863-867. https ://doi. org /10. 1158 /0008-5472. CAN-06-1078
141. Yesair, D.W., and P. Himmelfarb. 1970. Hydrolysis of conjugated bile acids by cell-free extracts from aerobic bacteria. Appl. Microbiol. 19:295-300
142. Zhang, Y., H.R. Kast-Woelbern, and P.A. Edwards. 2003. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. J. Biol. Chem. 278:104-110. https ://doi. org /10. 1074 /jbc. M209505200
143. Zhang, Y., F.Y. Lee, G. Barrera, H. Lee, C. Vales, F.J. Gonzalez, T.M. Willson, and P.A. Edwards. 2006. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc. Natl. Acad. Sci. USA. 103:1006-1011. https ://doi. org /10. 1073 /pnas. 0506982103
144. Zhang, Y., X. Ge, L.A. Heemstra, W.D. Chen, J. Xu, J.L. Smith, H. Ma, N. Kasim, P.A. Edwards, and C.M. Novak. 2012. Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ ob mice. Mol. Endocrinol. 26:272-280. https ://doi. org /10. 1210 /me. 2011-1157
145. Zhou, M., X. Wang, V. Phung, D.A. Lindhout, K. Mondal, J.Y. Hsu, H. Yang, M. Humphrey, X. Ding, T. Arora, et al. 2014. Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19. Cancer Res. 74:3306-3316. https ://doi. org /10. 1158 /0008-5472. CAN-14-0208
146. Zieve, F.J., M.F. Kalin, S.L. Schwartz, M.R. Jones, and W.L. Bailey. 2007. Results of the glucose-lowering effect of WelChol study (GLO WS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes. Clin. Ther. 29:74-83. https ://doi. org /10. 1016 /j. clinthera. 2007. 01. 003